Aspira Pathlab and Diagnostics Ltd Q4FY25 PAT at Rs. 72.33 lakhs

Aspira Pathlab & Diagnostics Limited has reported Standalone financial results for the period ended March 31, 2025.

Financial Results (Q4 FY2025) - QoQ Comparison

The company has reported total income of Rs. 5.9071 crores during the period ended March 31, 2025 as compared to Rs. 5.4961 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. 0.7233 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 0.3766 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. 0.70 for the period ended March 31, 2025 as compared to Rs. 0.37 for the period ended December 31, 2024.

Financials	Q4 FY2025	Q3 FY2025	% Change
Total Income	₹ 5.9071 crs	₹5.4961 crs	7.48%
Net Profit	₹0.7233 crs	₹0.3766 crs	92.06%
EPS	₹0.70	₹0.37	89.19%

Financial Results (Q4 FY2025) - YoY Comparison

The company has reported total income of Rs. 5.9071 crores during the period ended March 31, 2025 as compared to Rs.3.8940 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.0.7233 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.-0.5026 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.0.70 for the period ended March 31, 2025 as compared to Rs.-0.49 for the period ended March 31, 2024.

Financials	Q4 FY2025	Q4 FY2024	% Change
Total Income	₹ 5.9071 crs	₹3.8940 crs	51.70%
Net Profit	₹0.7233 crs	₹-0.5026 crs	243.91%
EPS	₹0.70	₹-0.49	242.86%

Financial Results (Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.22.3879 crores during the Financial Year ended March 31, 2025 as compared to Rs.13.6260 crores during the Financial Year ended March 31, 2024.

The company has posted net profit / (loss) of Rs.2.0726 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.-2.6722 crores for the Financial Year ended March 31, 2024.

The company has reported EPS of Rs.2.01 for the Financial Year ended March 31, 2025 as compared to Rs.-2.60 for the Financial Year ended March 31, 2024.

Financials	Year Ended FY2025	Year Ended FY2024	% Change
Total Income	₹22.3879 crs	₹13.6260 crs	64.30%
Net Profit	₹2.0726 crs	₹-2.6722 crs	177.56%
EPS	₹2.01	₹-2.60	177.31%

Shares of Aspira Pathlab & Diagnostics Limited was last trading in BSE at Rs. 53.25 as compared to the previous close of Rs. 56.05. The total number of shares traded during the day was 4143 in over 50 trades.

The stock hit an intraday high of Rs. 55.60 and intraday low of 53.25. The net turnover during the day was Rs. 223020.00.

Source : Equity Bulls

Keywords

AspiraPathlabandDiagnostics Q4FY25 Q4FY2025 FY2025 ResultUpdate